210 related articles for article (PubMed ID: 31813133)
1. Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers.
Mahfouz M; Nguyen H; Tu J; Diaz CR; Anjan S; Brown S; Bosire K; Carrasquillo O; Martin P; Jones PD
Dig Dis Sci; 2020 Sep; 65(9):2551-2561. PubMed ID: 31813133
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis B and liver cancer risks among Asian immigrants in New York City: Results from a large, community-based screening, evaluation, and treatment program.
Pollack HJ; Kwon SC; Wang SH; Wyatt LC; Trinh-Shevrin C;
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2229-39. PubMed ID: 25368398
[TBL] [Abstract][Full Text] [Related]
3. Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.
Hearn B; Chasan R; Bichoupan K; Suprun M; Bagiella E; Dieterich DT; Perumalswami P; Branch AD; Huprikar S
Clin Infect Dis; 2015 Dec; 61(11):1742-8. PubMed ID: 26240206
[TBL] [Abstract][Full Text] [Related]
4. A mixed-methods approach to understanding perceptions of hepatitis B and hepatocellular carcinoma among ethnically diverse Black communities in South Florida.
Jones P; Soler J; Solle NS; Martin P; Kobetz E
Cancer Causes Control; 2020 Dec; 31(12):1079-1091. PubMed ID: 32964364
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers.
Khalili M; Guy J; Yu A; Li A; Diamond-Smith N; Stewart S; Chen M; Nguyen T
Dig Dis Sci; 2011 May; 56(5):1516-23. PubMed ID: 21046247
[TBL] [Abstract][Full Text] [Related]
6. Increasing burden of advanced hepatocellular carcinoma in New Zealand-the need for better surveillance.
Schauer C; Mules T; Rijnsoever MV; Gane E
N Z Med J; 2020 May; 133(1515):25-34. PubMed ID: 32438374
[TBL] [Abstract][Full Text] [Related]
7. Adherence to screening for hepatocellular carcinoma among patients with cirrhosis or chronic hepatitis B in a community setting.
Wong CR; Garcia RT; Trinh HN; Lam KD; Ha NB; Nguyen HA; Nguyen KK; Levitt BS; Nguyen MH
Dig Dis Sci; 2009 Dec; 54(12):2712-21. PubMed ID: 19876735
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for early-onset and late-onset hepatocellular carcinoma in Asian immigrants with hepatitis B in the United States.
Wan DW; Tzimas D; Smith JA; Kim S; Araujo J; David R; Lobach I; Sarpel U
Am J Gastroenterol; 2011 Nov; 106(11):1994-2000. PubMed ID: 21912436
[TBL] [Abstract][Full Text] [Related]
9. Knowledge of hepatocellular carcinoma screening guidelines and clinical practices among gastroenterologists.
Sharma P; Saini SD; Kuhn LB; Rubenstein JH; Pardi DS; Marrero JA; Schoenfeld PS
Dig Dis Sci; 2011 Feb; 56(2):569-77. PubMed ID: 20978844
[TBL] [Abstract][Full Text] [Related]
10. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low-level viremia.
Paik N; Sinn DH; Lee JH; Oh IS; Kim JH; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
Liver Int; 2018 Jan; 38(1):68-75. PubMed ID: 28581248
[TBL] [Abstract][Full Text] [Related]
12. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma.
Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K
Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438
[No Abstract] [Full Text] [Related]
13. Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients.
Kim GA; Han S; Choi GH; Choi J; Lim YS
Aliment Pharmacol Ther; 2020 Jun; 51(11):1169-1179. PubMed ID: 32291781
[TBL] [Abstract][Full Text] [Related]
14. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
Ringelhan M; O'Connor T; Protzer U; Heikenwalder M
J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Carcinoma Screening and Surveillance: Practice Guidelines and Real-Life Practice.
Zhao C; Nguyen MH
J Clin Gastroenterol; 2016 Feb; 50(2):120-33. PubMed ID: 26583266
[TBL] [Abstract][Full Text] [Related]
16. Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus-associated hepatocellular carcinoma.
Wang Q; Luan W; Villanueva GA; Rahbari NN; Yee HT; Manizate F; Hiotis SP
J Dig Dis; 2012 Apr; 13(4):214-8. PubMed ID: 22435506
[TBL] [Abstract][Full Text] [Related]
17. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Nguyen VT; Amin J; Law MG; Dore GJ
J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
[TBL] [Abstract][Full Text] [Related]
18. African Immigrants in New York City with Hepatitis B-Related Hepatocellular Carcinoma Demonstrate High Morbidity and Mortality.
Carr J; Cha DE; Shaltiel T; Zheng S; Siderides C; Golas B; Labow D; Magge D; Cohen N; Branch A; Sarpel U
J Immigr Minor Health; 2022 Apr; 24(2):327-333. PubMed ID: 33907933
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting clinician educator encouragement of routine HIV testing among trainees.
Berkenblit GV; Sosman JM; Bass M; Gebrekristos HT; Cofrancesco J; Sullivan LE; Cook RL; Edison M; Bashook PG; Korthuis PT
J Gen Intern Med; 2012 Jul; 27(7):839-44. PubMed ID: 22302354
[TBL] [Abstract][Full Text] [Related]
20. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.
Wei Q; Xu X; Ling Q; Zhou B; Zheng SS
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):251-5. PubMed ID: 23742769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
